Drug Information

Drug General Information
Drug ID
D0K0OR
Former ID
DNC013508
Drug Name
1-(5-(pyridin-2-yl)oxazol-2-yl)octan-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529193]
Structure
Download
2D MOL

3D MOL
Formula
C16H20N2O2
Canonical SMILES
CCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2
InChI
1S/C16H20N2O2/c1-2-3-4-5-6-10-14(19)16-18-12-15(20-16)13-9-7-8-11-17-13/h7-9,11-12H,2-6,10H2,1H3
InChIKey
VLJKBQYNIDBQEJ-UHFFFAOYSA-N
PubChem Compound ID
11173328
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529193]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529193Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. Epub 2007 Nov 6.Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.
Ref 529193Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. Epub 2007 Nov 6.Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.